Clinical Trials
1
Active:0
Completed:1
Trial Phases
0 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Real Life Study on Iron Isomaltoside 1000 in the Treatment of ID in CKD, Heart Failure, ObGyn, IBD, Cancer and Elective Surgery (Real-CHOICE).
Completed
- Conditions
- Iron-Deficiency AnemiaIron-Deficiency
- First Posted Date
- 2020-03-24
- Last Posted Date
- 2023-07-19
- Lead Sponsor
- Pierre Fabre Pharma AG
- Target Recruit Count
- 327
- Registration Number
- NCT04318405
- Locations
- 🇨🇭
21, Basel, Switzerland
🇨🇭9, Basel, Switzerland
🇨🇭1, Bern, Switzerland
News
No news found